Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
98 hedge funds and large institutions have $144M invested in Avid Bioservices, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 27 closing their positions.
5% more call options, than puts
Call options by funds: $377K | Put options by funds: $359K
6% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 32
14% less funds holding
Funds holding: 114 → 98 (-16)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
34% less capital invested
Capital invested by funds: $220M → $144M (-$75.5M)
48% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
+$8.63M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.79M |
| 3 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$1.24M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
+$1.05M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$622K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$2.06M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.02M |
| 3 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$2M |
| 4 |
Millennium Management
New York
|
-$2M |
| 5 |
AC
AltraVue Capital
Bellevue,
Washington
|
-$1.58M |
CDMO Hedge Fund Activity: Q1 2020 in Review
98 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2020, worth a combined $144M — down 34% from $220M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of CDMO and 14 opened new positions — a net loss of 13 holders — while 32 trimmed existing stakes and 30 added.
The largest buyer was ISZO Capital Management, adding an estimated $8.63M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $2.06M sold.
- 98 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2020, down from 114 in Q4 2019.
- Funds reported $144M of Avid Bioservices, Inc. Common Stock stock for Q1 2020, down 34% quarter-over-quarter.
- 14 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2020 and 27 closed out, a net change of -13 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2020 was ISZO Capital Management, an estimated $8.63M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2020 was Two Sigma Investments, an estimated $2.06M sold.
Based on aggregated 13F filings for Q1 2020.